Top

Published in:

01-02-2017 | Literatur kommentiert

Bildgeführte intensitätsmodulierte Strahlentherapie vermindert die gastrointestinalen Spätfolgen nach Radiotherapie des Prostatakarzinoms

Authors: Dr. med. Tobias Finazzi, Prof. Dr. med. Matthias Guckenberger, MD

Published in: Strahlentherapie und Onkologie | Issue 2/2017

Auszug

Die perkutane Strahlentherapie ist eine etablierte Standardbehandlung des lokalisierten Prostatakarzinoms. Wortel et al. verglichen nun anhand von zwei Patientenkohorten aus zwei prospektiven Studien die Langzeitnebenwirkungen nach einer bildgeführten intensitätsmodulierten Radiotherapie (IG-IMRT) und einer dreidimensionalen (3-D) konformalen Strahlentherapie (3D-CRT), um die Hypothese einer Reduktion der Spätfolgen nach IG-IMRT zu überprüfen. …

Incrocci L, Wortel RC, Alemayehu WG et al (2016) Hypofractionated versus conventionally fractionated radiotherapy for patients with localised prostate cancer (HYPRO): Final efficacy results from a randomised, multicentre, open-label, phase 3 trial. Lancet Oncol 17:1061–1069CrossRefPubMed

Peeters ST, Heemsbergen WD, Koper PC et al (2006) Dose-response in radiotherapy for localized prostate cancer: Results of the dutch multicenter randomized phase iii trial comparing 68 gy of radiotherapy with 78 gy. J Clin Oncol 24:1990–1996CrossRefPubMed

Zelefsky MJ, Levin EJ, Hunt M et al (2008) Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 70:1124–1129CrossRefPubMed

Michalski JM, Yan Y, Watkins-Bruner D et al (2013) Preliminary toxicity analysis of 3‑dimensional conformal radiation therapy versus intensity modulated radiation therapy on the high-dose arm of the radiation therapy oncology group 0126 prostate cancer trial. Int J Radiat Oncol Biol Phys 87:932–938CrossRefPubMed

Luxton G, Hancock SL, Boyer AL (2004) Dosimetry and radiobiologic model comparison of imrt and 3 d conformal radiotherapy in treatment of carcinoma of the prostate. Int J Radiat Oncol Biol Phys 59:267–284CrossRefPubMed

Bekelman JE, Mitra N, Efstathiou J et al (2011) Outcomes after intensity-modulated versus conformal radiotherapy in older men with nonmetastatic prostate cancer. Int J Radiat Oncol Biol Phys 81:e325–e334CrossRefPubMedPubMedCentral

Michalski JM, Gay H, Jackson A et al (2010) Radiation dose-volume effects in radiation-induced rectal injury. Int J Radiat Oncol Biol Phys 76:S123–S129CrossRefPubMedPubMedCentral

Sveistrup J, af Rosenschold PM, Deasy JO et al (2014) Improvement in toxicity in high risk prostate cancer patients treated with image-guided intensity-modulated radiotherapy compared to 3 d conformal radiotherapy without daily image guidance. Radiat Oncol 9:44CrossRefPubMedPubMedCentral

Zelefsky MJ, Kollmeier M, Cox B et al (2012) Improved clinical outcomes with high-dose image guided radiotherapy compared with non-igrt for the treatment of clinically localized prostate cancer. Int J Radiat Oncol Biol Phys 84:125–129CrossRefPubMed

10.

Fiorino C, Valdagni R, Rancati T et al (2009) Dose-volume effects for normal tissues in external radiotherapy: Pelvis. Radiother Oncol 93:153–167CrossRefPubMed

11.

McNair HA, Hansen VN, Parker CC et al (2008) A comparison of the use of bony anatomy and internal markers for offline verification and an evaluation of the potential benefit of online and offline verification protocols for prostate radiotherapy. Int J Radiat Oncol Biol Phys 71:41–50CrossRefPubMed

12.

Nijkamp J, Pos FJ, Nuver TT et al (2008) Adaptive radiotherapy for prostate cancer using kilovoltage cone-beam computed tomography: First clinical results. Int J Radiat Oncol Biol Phys 70:75–82CrossRefPubMed

13.

de Boer HC, van Os MJ, Jansen PP et al (2005) Application of the no action level (nal) protocol to correct for prostate motion based on electronic portal imaging of implanted markers. Int J Radiat Oncol Biol Phys 61:969–983CrossRefPubMed

14.

Wortel RC, Incrocci L, Pos FJ et al (2015) Acute toxicity after image-guided intensity modulated radiation therapy compared to 3 d conformal radiation therapy in prostate cancer patients. Int J Radiat Oncol Biol Phys 91:737–744CrossRefPubMed

15.

Wortel RC, Witte MG, van der Heide UA et al (2015) Dose-surface maps identifying local dose-effects for acute gastrointestinal toxicity after radiotherapy for prostate cancer. Radiother Oncol 117:515–520CrossRefPubMed

Title: Bildgeführte intensitätsmodulierte Strahlentherapie vermindert die gastrointestinalen Spätfolgen nach Radiotherapie des Prostatakarzinoms
Authors: Dr. med. Tobias Finazzi
Prof. Dr. med. Matthias Guckenberger, MD
Publication date: 01-02-2017
Publisher: Springer Berlin Heidelberg
Published in: Strahlentherapie und Onkologie / Issue 2/2017
Print ISSN: 0179-7158
Electronic ISSN: 1439-099X
DOI: https://doi.org/10.1007/s00066-016-1088-3

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Bildgeführte intensitätsmodulierte Strahlentherapie vermindert die gastrointestinalen Spätfolgen nach Radiotherapie des Prostatakarzinoms

Auszug

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Auszug

Please log in to get access to this content

Other articles of this Issue 2/2017

Analysis of risk factors for pulmonary complications in patients with limited-stage small cell lung cancer

Erratum to: Fractionated vs. single-fraction stereotactic radiotherapy in patients with vestibular schwannoma

Prognostic role of patient gender in limited-disease small-cell lung cancer treated with chemoradiotherapy

Analyses of patterns-of-failure and prognostic factors according to radiation fields in early-stage Hodgkin lymphoma

Inklusion von Oxaliplatin in die multimodale Behandlung des lokal fortgeschrittenen Rektumkarzinoms

Changes in pulmonary function and influencing factors after high-dose intrathoracic radio(chemo)therapy